MORGAN STANLEY - FORTRESS BIOTECH INC ownership

FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 80 filers reported holding FORTRESS BIOTECH INC in Q1 2022. The put-call ratio across all filers is 1.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of FORTRESS BIOTECH INC
ValueSharesWeighting
Q3 2023$20,108
-79.0%
69,266
-60.2%
0.00%
Q2 2023$95,690
-34.0%
173,981
-1.5%
0.00%
Q1 2023$144,906
+105.6%
176,715
+64.3%
0.00%
Q4 2022$70,465
-10.8%
107,579
+16.7%
0.00%
Q3 2022$79,000
-43.2%
92,187
-44.4%
0.00%
Q2 2022$139,000
-34.1%
165,859
+6.7%
0.00%
Q1 2022$211,000
-60.6%
155,413
-27.5%
0.00%
Q4 2021$536,000
-41.4%
214,232
-24.6%
0.00%
Q3 2021$914,000
-4.1%
283,956
+6.4%
0.00%
Q2 2021$953,000
+782.4%
266,945
+768.2%
0.00%
Q1 2021$108,000
-59.9%
30,747
-63.7%
0.00%
Q4 2020$269,000
-92.8%
84,734
-90.9%
0.00%
-100.0%
Q3 2020$3,750,000
+5108.3%
928,153
+3331.6%
0.00%
Q2 2020$72,000
+56.5%
27,047
+10.4%
0.00%
Q1 2020$46,000
-25.8%
24,500
+1.7%
0.00%
Q4 2019$62,000
+100.0%
24,100
+12.2%
0.00%
Q3 2019$31,000
-55.7%
21,482
-53.6%
0.00%
Q2 2019$70,000
+40.0%
46,273
+65.7%
0.00%
Q1 2019$50,000
-35.1%
27,922
-68.8%
0.00%
Q4 2018$77,000
-77.7%
89,407
-58.5%
0.00%
Q3 2018$345,000
-56.8%
215,606
-19.4%
0.00%
Q2 2018$798,000
-14.1%
267,599
+31.0%
0.00%
Q1 2018$929,000
+106.0%
204,199
+80.6%
0.00%
Q4 2017$451,000
-7.2%
113,068
+2.9%
0.00%
Q3 2017$486,000
+116.0%
109,840
+131.7%
0.00%
Q2 2017$225,000
-36.8%
47,408
-50.8%
0.00%
Q1 2017$356,000
-39.5%
96,278
-55.9%
0.00%
Q4 2016$588,000
+1052.9%
218,188
+1153.8%
0.00%
Q3 2016$51,000
+750.0%
17,402
+728.7%
0.00%
Q2 2016$6,000
-96.0%
2,100
-95.7%
0.00%
Q1 2016$151,000
+420.7%
48,656
+370.9%
0.00%
Q4 2015$29,000
-29.3%
10,332
-34.8%
0.00%
Q3 2015$41,000
+86.4%
15,855
+144.9%
0.00%
Q2 2015$22,0006,4750.00%
Other shareholders
FORTRESS BIOTECH INC shareholders Q1 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 3,887,500$12,323,0001.61%
Nantahala Capital Management 8,680,909$27,518,0000.85%
SHIKIAR ASSET MANAGEMENT INC 558,500$1,770,0000.64%
CPWM, LLC 506,267$1,605,0000.15%
Sandbox Financial Partners, LLC 14,650$46,0000.04%
Sepio Capital, LP 134,748$427,0000.04%
683 Capital Management, LLC 200,000$635,0000.03%
GSA CAPITAL PARTNERS LLP 22,928$73,0000.01%
Virtu Financial LLC 33,333$106,0000.01%
B. Riley Wealth Advisors, Inc. 55,510$176,0000.01%
View complete list of FORTRESS BIOTECH INC shareholders